Importer of Controlled Substances Registration, 13954 [2019-06845]

Download as PDF 13954 Federal Register / Vol. 84, No. 67 / Monday, April 8, 2019 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–392] [Docket No. DEA–392] Importer of Controlled Substances Registration Importer of Controlled Substances Registration [Docket No. DEA–392] ACTION: Notice of registration. ACTION: SUMMARY: The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of a schedule I controlled substance. SUMMARY: The company listed below applied to be registered as an importer of a basic class of controlled substance. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for this notice. SUPPLEMENTARY INFORMATION: Company FR docket Almac Clinical Services Incorp (ACSI). 84 FR 3253 The company listed below applied to be registered as an importer of various basic classes of controlled substances. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. Published February 11, 2019. Company FR docket Usona Institute ....................... 83 FR 64365 ACTION: Notice of registration. The registrant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of various classes of schedule I controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as a bulk manufacturer of basic classes of schedule I controlled substances. Information on a previously published notice is listed below. No comments or objections were submitted for the notice. SUMMARY: The applicant listed below has submitted an application for registration to the Drug Enforcement Administration (DEA) to become an importer of schedule I controlled substances. SUPPLEMENTARY INFORMATION: jbell on DSK30RV082PROD with NOTICES Notice of registration. Bulk Manufacturer of Controlled Substances Registration Published December 14, 2018. Company FR docket Usona Institute .......... 83 FR 64364 Published December 14, 2018. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this applicant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed applicant to import the applicable basic class of schedule I controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security system, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer of a schedule I controlled substance to the above listed company. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed applicant to import the applicable basic classes of schedule I controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I controlled substances to the above listed company. Dated: March 21, 2019. John J. Martin, Assistant Administrator. Dated: March 21, 2019. John J. Martin, Assistant Administrator. Drug Enforcement Administration [FR Doc. 2019–06845 Filed 4–5–19; 8:45 am] [FR Doc. 2019–06847 Filed 4–5–19; 8:45 am] BILLING CODE 4410–09–P BILLING CODE 4410–09–P Importer of Controlled Substances Application: SpecGx LLC Dated: March 21, 2019. John J. Martin, Assistant Administrator. [FR Doc. 2019–06848 Filed 4–5–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [Docket No. DEA–392] ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written DATES: VerDate Sep<11>2014 17:45 Apr 05, 2019 Jkt 247001 PO 00000 Frm 00093 Fmt 4703 Sfmt 4703 E:\FR\FM\08APN1.SGM 08APN1

Agencies

[Federal Register Volume 84, Number 67 (Monday, April 8, 2019)]
[Notices]
[Page 13954]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06845]



[[Page 13954]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The applicant listed below has submitted an application for 
registration to the Drug Enforcement Administration (DEA) to become an 
importer of a schedule I controlled substance.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of a basic class of controlled substance. 
Information on the previously published notice is listed in the table 
below. No comments or objections were submitted and no requests for a 
hearing were submitted for this notice.

------------------------------------------------------------------------
             Company                   FR docket          Published
------------------------------------------------------------------------
Almac Clinical Services Incorp     84 FR 3253......  February 11, 2019.
 (ACSI).
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed applicant to 
import the applicable basic class of schedule I controlled substance is 
consistent with the public interest and with United States obligations 
under international treaties, conventions, or protocols in effect on 
May 1, 1971. The DEA investigated the company's maintenance of 
effective controls against diversion by inspecting and testing the 
company's physical security system, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer of a schedule I controlled substance to the above listed 
company.

    Dated: March 21, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-06845 Filed 4-5-19; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.